RecruitingNCT06162247

Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)

Sponsor

Federico II University

Enrollment

5,000 participants

Start Date

Nov 20, 2023

Study Type

OBSERVATIONAL

Conditions

Acute Coronary Syndrome Cardiogenic Shock Acute Heart Failure Acute Cardiovascular Disease

Summary

This protocol proposes to prospectively evaluate current epidemiology, pharmacologic and invasive management and clinical outcomes of patients with acute cardiovascular diseases admitted at our ICCU.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Acute cardiovascular disease admitted at our ICCU
Age ≥18 years;
Written informed consent.

Exclusion Criteria1

\) Patients not providing consent to data collection

Locations(1)

Department of Advanced Biomedical Sciences, University Federico II of Naples

Napoli, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06162247

Related Trials

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

NCT044194801 location

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

NCT072939235 locations

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

NCT0600819780 locations

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure

NCT0539276469 locations

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

NCT0739765021 locations